Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molsentech is a Taiwan-based biotechnology company specializing in the development of semiconductor-based biosensing technology. The company was founded by Dr. Shih-Ting Hong to commercialize Biologically Sensitive Field-Effect Transistor (Bio-FET) technology for rapid medical diagnostics. Molsentech's platform offers high sensitivity and specificity for detecting various biomarkers, including proteins and nucleic acids, without the need for complex sample preparation or labeling. Their products are designed for point-of-care applications in infectious disease monitoring, oncology, and emergency medicine, aiming to provide real-time results that improve patient outcomes and healthcare efficiency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shih-Ting Hong.